Cour

formerly COUR Pharma

Reprogramming the immune system. Restoring lives. | COUR Pharma

Evanston, United States · Founded 2015 · $185.0M raised

Headquarters
Evanston, Illinois
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$185.0M
Last Round
$50.0M Series BJun 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

COUR is a clinical-stage biotechnology company developing disease-modifying therapies for autoimmune diseases. Its proprietary COUR nanoparticle platform is designed to induce antigen-specific immune tolerance, targeting the root mechanisms of disease without broadly suppressing normal immune function. The company is advancing programs in primary biliary cholangitis, type 1 diabetes, myasthenia gravis, and celiac disease.

Summary

Cour is a Biotech company based in Evanston, United States, founded in 2015. It has raised $185.0M in total across 3 rounds, most recently a $50.0M Series B round in Jun 2026. Investors include Lumira Ventures, Roche Venture Fund and Alpha Wave Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2026
$50.0M

Sign up to see all 3 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cour on Indexed.vc
<a href="https://indexed.vc/companies/cour"><img src="https://indexed.vc/api/badge/company/cour" alt="Cour on Indexed.vc" width="260" height="76" /></a>